CASE BioMed and Wyss Zurich announce collaboration

13-06-2024 – The Center of Advanced Studies on Entrepreneurship in BioMedicine (CASE BioMed) at the Università della Svizzera italiana (USI) and the Wyss Zurich Translational Center (Wyss Zurich) have signed a Memorandum of Understanding (MoU) in June 2024 to enter in a long-term collaboration.

WZ x CASE Biomed

The MoU expresses the mutual commitment of both parties to cooperate on life sciences entrepreneurship training programs along a North-South alliance in Switzerland. While the existing entrepreneurship training programs that have been developed by CASE BioMed will continue to take place in Ticino, new offers will be jointly developed in Zurich.

CASE BioMed offers a series of leading-edge comprehensive advanced programmes – BioBusiness, MedTech Business, eHealth Business – providing young life sciences companies with the theoretical and project-based practical skills needed to develop, fund and market biomedical innovations. The training programs are internationally recognized, with approximately 90% of the participants coming from other Swiss and European Universities. 60% of the students are from the Greater Zurich Area.

Dr. Melanie Wiesel, Head of Operations at Wyss Zurich, added “Our collaboration with CASE BioMed will boost existing offerings and support available in the German-speaking region of Switzerland. We are excited for our joint offerings and for life sciences researchers to reap the benefits of these programs”.